首页 > 市场调查报告书 > 医疗设备

心血管设备

市场调查报告书

商品编码

1563405

植入式医疗设备市场规模、份额、成长分析、按产品、按生物材料、按最终用途、按地区 - 行业预测，2024-2031 年

Implantable Medical Devices Market Size, Share, Growth Analysis, By Product (Cardiovascular Implants, Orthopedic Implants), By Biomaterial (Ceramic, Metallic), By End Use (Hospitals, Outpatient Facilities), By Region - Industry Forecast 2024-2031

出版日期: 2024年09月29日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球植入式医疗设备市场规模将为905亿美元，从2023年的961.1亿美元成长到2031年的1,555.1亿美元，并预计在预测期内（2024-2031年）成长。成长率为6.20%）。

植入式医疗设备放置在体内或身体上，旨在执行多种功能。许多这些装置充当人工关节或零件来取代缺失的身体部位。其他人可能发挥支持作用，例如给药、监测生物过程或提供身体帮助。根据其用途，植入可以永久保留在原位以进行诊断、监测和治疗，也可以在不再需要其功能时将其移除。长期植入的优点是能够在稳定的温度环境中运行，同时面临复杂的负载条件和对长设备寿命日益增长的需求等挑战。随着预期寿命的延长，与老龄化相关的健康状况显着增加，增加了对旨在延长寿命的医疗辅助器具的需求。这包括治疗方法、植入、人工关节和持续药物治疗的创新。由于医疗技术和材料科学的进步，用于製造这些设备的材料范围，包括组织、金属、骨骼、聚合物、皮肤和陶瓷，预计在不久的将来将进一步扩大。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Medtronic（Ireland）
Abbott Laboratories（US）
Johnson & Johnson（US）
Boston Scientific Corporation（US）
Smith & Nephew plc（UK）
Stryker（US）
Cochlear Limited（Australia）
Integra LifeSciences（US）
LivaNova PLC（UK）
Biotronik SE and Co. KG（Germany）
Zimmer Biomet Holdings, Inc.（US）
Edwards Lifesciences Corporation（US）
Hearing Life（US）
Nevro Corp.（US）
Orthofix Medical Inc.（US）
NuVasive, Inc.（US）
WL Gore & Associates, Inc.（US）
AngioDynamics, Inc.（US）
Ramsay Sante（France）
Hologic, Inc.（US）
Abiomed, Inc.（US）
Straumann Holding AG（Switzerland）
KARL STORZ SE & Co. KG（Germany）

简介目录

Product Code: SQMIG35A2510

Global Implantable Medical Devices Market size was valued at USD 90.50 billion in 2022 and is poised to grow from USD 96.11 billion in 2023 to USD 155.51 billion by 2031, growing at a CAGR of 6.20% during the forecast period (2024-2031).

Implantable medical devices are designed to be placed either inside the body or on its surface, serving various functions. Many of these devices act as prostheses or artificial components to replace missing body parts. Other implants play supportive roles, such as administering medication, monitoring biological processes, or providing physical assistance. Depending on their purpose, implants can either remain in place permanently for diagnostic, monitoring, or therapeutic reasons, or be removed once their function is no longer needed. Long-term implants benefit from their ability to operate in a stable temperature environment, although they face challenges like complex loading conditions and increasing demands for device longevity. With rising life expectancy, there has been a notable increase in age-related health conditions, leading to a greater need for medical aids designed to extend life. This includes innovations in therapies, implants, prostheses, and ongoing pharmacological treatments. The range of materials used in creating these devices-including tissues, metals, bones, polymers, skin, and ceramics-is expected to expand further in the near future, driven by advancements in medical technology and materials science.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Implantable Medical Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Implantable Medical Devices Market Segmental Analysis

Global Implantable Medical Devices Market is segmented by Product, Biomaterial, End Use, and region. Based on Product, the market is segmented into Cardiovascular Implants, Orthopedic Implants, Ophthalmology Implants, Dental Implants, Aesthetic Implants, and Neurology Implants. Based on Biomaterial, the market is segmented into Ceramic, Metallic, Polymers, and Natural. Based on End Use, the market is segmented into Hospitals, Outpatient Facilities, and Specialty Clinics & Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Implantable Medical Devices Market

The growth of the implantable medical devices industry is significantly driven by the rising incidence of disorders across various medical fields, including cardiovascular, ophthalmology, orthopedics, plastic surgery, dental care, and neurology. For example, cardiovascular diseases such as coronary artery disease (CAD), congenital heart disease (CHD), and strokes are major contributors to global mortality rates. The World Health Organization (WHO) reports that approximately 17.9 million deaths occur annually due to cardiovascular conditions, accounting for about 31% of global deaths. Within this, around 7.4 million deaths are attributed to CHD, while approximately 6.7 million are due to strokes. Projections indicate that by 2030, cardiovascular diseases will be responsible for an estimated 23.6 million deaths worldwide. The prevalence of these diseases is largely driven by factors such as unhealthy diets, excessive alcohol consumption, tobacco use, and lack of physical activity. This increasing prevalence results in a significant number of deaths and is expected to continue rising in the future. Consequently, this growing trend is anticipated to expand the market for implantable medical devices, as there will be an increasing demand for innovative solutions to manage and treat these conditions effectively.

Restraints in the Global Implantable Medical Devices Market

The market growth for implantable medical devices may be constrained by the high costs associated with implantation procedures and a shortage of trained medical professionals. The significant expense of these procedures can limit accessibility and reduce the adoption rate of new technologies. Additionally, the scarcity of skilled professionals in the field further exacerbates these challenges, as it impacts the availability and quality of surgical interventions.

Market Trends of the Global Implantable Medical Devices Market

A significant trend shaping the global implantable medical devices market is the emergence of connected medical devices. These devices offer enhanced value and efficiency for healthcare providers by facilitating real-time data capture and transmission. Advances in connectivity technologies and supporting systems have given rise to the Internet of Medical Things (IoMT), which integrates various connected devices to improve patient care and operational efficiency. As the adoption of connected medical devices continues to rise, it is expected to open up numerous opportunities in the market in the coming years.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Implantable Medical Devices Market by Product

Market Overview
Cardiovascular Implants
Orthopedic Implants
Ophthalmology Implants
Dental Implants
Aesthetic Implants
Neurology Implants

Implantable Medical Devices Market by Biomaterial

Market Overview
Ceramic
Metallic
Polymers
Natural

Implantable Medical Devices Market by End Use

Market Overview
Hospitals
Outpatient Facilities
Specialty Clinics & Centers

Implantable Medical Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cochlear Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE and Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hearing Life (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NuVasive, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
W. L. Gore & Associates, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ramsay Sante (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abiomed, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Straumann Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KARL STORZ SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments